This inventor holds 2 USPTO granted patents. Top assignees: Northwestern University, University of Southern California, Other. Active years: 2001-2009.
Company Filing History:
1 out of 2,207 
1 out of 1,690 
1 out of 834,307 Years Active: 2001-2009
Title: Caleb E Finch: Innovator in Amyloid Beta Research
Introduction
Caleb E Finch is a prominent inventor based in Altadena, CA, known for his significant contributions to the field of amyloid beta research. With a total of 2 patents, Finch has made strides in understanding the molecular mechanisms associated with neurodegenerative diseases.
Latest Patents
Finch's latest patents focus on the composition and applications of amyloid beta-derived dementing ligands (ADDLs). The first patent describes a new composition of matter involving ADDLs, which are soluble globular non-fibrillar oligomeric structures capable of activating specific cellular processes. This invention includes methods for assaying the formation, presence, receptor protein binding, and cellular activities of ADDLs. Additionally, it encompasses assay methods and inhibitor molecules for cellular signaling molecules activated by ADDLs, as well as molecules that block proteins promoting the formation of ADDLs.
Career Highlights
Throughout his career, Finch has worked with esteemed institutions, including Northwestern University. His research has significantly advanced the understanding of amyloid beta and its implications in neurodegenerative diseases.
Collaborations
Finch has collaborated with notable colleagues such as Grant A Krafft and William L Klein, contributing to the collective knowledge in the field of amyloid research.
Conclusion
Caleb E Finch's innovative work in amyloid beta research has led to important advancements in understanding neurodegenerative diseases. His patents and collaborations reflect his commitment to scientific progress and the potential for future breakthroughs in this critical area of study.